Dear Colleagues,
the COVID-19 pandemic has been the current dramatic reality for over a year. This situation has not only caused significant mortality and morbidity due to SARS-CoV-2 itself but has also compromised the level of almost all other health medical services. In this context, the treatment of the Gynaecologic Oncology patients has also encountered significant difficulties, often necessitating adaptations to the standard treatment protocols.
This webinar is the first that is organized by our Department as ESGO-certified center, and is designated to discuss the treatment of the Gynaecologic Oncology patients in the context of COVID-pandemic. Specifically, it sets in the center of interest both necessary alterations often needed to be established because of COVID-pandemic, as well as, the reconsideration of all aspects of treatment in the current situation. It is addressed not only to Gynaecologic Oncologists but also to all relative medical specialties, such as Medical Oncologists, Radiotherapists, Pathologists, Radiologists as well as other medical and paramedical professionals enrolled in the treatment of the Gynaecologic Oncology patient.
We would exceptionally like to thank the European Society of Gynaecologic Oncology (ESGO) and the French Society of Gynaecological Oncology for the privilege to endorse our webinar.
We cordially invite all you to join for free our webinar and therefore contribute to our continuous effort to advance treatment of the Gynaeocologic Oncology patients.
the COVID-19 pandemic has been the current dramatic reality for over a year. This situation has not only caused significant mortality and morbidity due to SARS-CoV-2 itself but has also compromised the level of almost all other health medical services. In this context, the treatment of the Gynaecologic Oncology patients has also encountered significant difficulties, often necessitating adaptations to the standard treatment protocols.
This webinar is the first that is organized by our Department as ESGO-certified center, and is designated to discuss the treatment of the Gynaecologic Oncology patients in the context of COVID-pandemic. Specifically, it sets in the center of interest both necessary alterations often needed to be established because of COVID-pandemic, as well as, the reconsideration of all aspects of treatment in the current situation. It is addressed not only to Gynaecologic Oncologists but also to all relative medical specialties, such as Medical Oncologists, Radiotherapists, Pathologists, Radiologists as well as other medical and paramedical professionals enrolled in the treatment of the Gynaecologic Oncology patient.
We would exceptionally like to thank the European Society of Gynaecologic Oncology (ESGO) and the French Society of Gynaecological Oncology for the privilege to endorse our webinar.
We cordially invite all you to join for free our webinar and therefore contribute to our continuous effort to advance treatment of the Gynaeocologic Oncology patients.
|
Konstantinos D. Dinas Associate Professor of Obstetrics and Gynecology Head of the 2nd Department of Obstetrics and Gynecology Hippokration General Hospital, Greece |
Alexios Papanikolaou Professor of Obstetrics and Gynecology 2nd Department of Obstetrics and Gynecology Hippokration General Hospital, Greece |
Stamatios Petousis Obstetrician – Gynaecologist Academic Fellow, 2nd Department of Obstetrics and Gynecology Hippokration General Hospital, Greece |
Dr. Frederic Guyon President of SFOG Head of Gynaeocologic Oncology Unit Institut Bergonie, Bordeaux, France |
